Evidence map›Paper›PMID 34999853›Full record

ArticleInternational journal of epidemiology2022

Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Merete Ellingjord-Dale, Sofia Christakoudi, Elisabete Weiderpass, Salvatore Panico, Laure Dossus, Anja Olsen, Anne Tjønneland, Rudolf Kaaks, Matthias B Schulze, Giovanna Masala and 11 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Microbiota as the unifying factor behind the hallmarks of cancer.Journal of cancer research and clinical oncology · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 14 institutions in 8 countries.

Merete Ellingjord-DaleDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK.
Sofia ChristakoudiDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK.ORCID 0000-0001-9219-4436
Elisabete WeiderpassInternational Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID 0000-0003-2237-0128
Salvatore PanicoDepartment of Clinical and Experimental Medicine, University of Naples Frederico II, Naples, Italy.ORCID 0000-0002-5498-8312
Laure DossusNutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Anja OlsenDepartment of Public Health, Aarhus University, Aarhus, Denmark.ORCID 0000-0003-4788-503X
Anne TjønnelandDanish Cancer Society, Research Center, Copenhagen, Denmark.ORCID 0000-0003-4385-2097
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Giovanna MasalaCancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy.
Inger T GramDepartment of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Guri SkeieDepartment of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Ann H RosendahlDepartment of Clinical Sciences Lund, Division of Oncology, Lund University and Skåne University Hospital, Lund, Sweden.
Malin SundDepartment of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.ORCID 0000-0002-7516-9543
Tim KeyCancer Epidemiology Unit, Nuffield, Department of Population Health, University of Oxford, Oxford, UK.
Pietro FerrariNutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Marc GunterNutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Alicia K HeathDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK.ORCID 0000-0001-6517-1300
Konstantinos K TsilidisDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK.ORCID 0000-0001-6795-6080
additional authors
Centre international de recherche sur le cancer · FRImperial College London · GBUiT The Arctic University of Norway · NOAarhus University · DKGerman Cancer Research Center · DEKing's College London · GBLund University · SEPiedmont Reference Center for Epidemiology and Cancer Prevention · ITUmeå University · SEUniversity of Copenhagen · DKUniversity of Ioannina · GRUniversity of Naples Federico II · ITUniversity of Oxford · GBUniversity of Potsdam · DE

Funding

Cancer Research UK 14136Cancer Research UK C570/A16491Cancer Research UK C8221/A19170Medical Research Council 1000143Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MR/M012190/1Medical Research Council MR/N003284/1World Health Organization 001
6 · The paper itself

Abstract

backgroundThe role of obesity and weight change in breast-cancer development is complex and incompletely understood. We investigated long-term weight change and breast-cancer risk by body mass index (BMI) at age 20 years, menopausal status, hormone replacement therapy (HRT) and hormone-receptor status.

methodsUsing data on weight collected at three different time points from women who participated in the European Prospective Investigation into Cancer and Nutrition (EPIC) study, we investigated the association between weight change from age 20 years until middle adulthood and risk of breast cancer.

resultsIn total, 150 257 women with a median age of 51 years at cohort entry were followed for an average of 14 years (standard deviation = 3.9) during which 6532 breast-cancer cases occurred. Compared with women with stable weight (±2.5 kg), long-term weight gain >10 kg was positively associated with postmenopausal breast-cancer risk in women who were lean at age 20 [hazard ratio (HR) = 1.42; 95% confidence interval 1.22-1.65] in ever HRT users (HR = 1.23; 1.04-1.44), in never HRT users (HR = 1.40; 1.16-1.68) and in oestrogen-and-progesterone-receptor-positive (ER+PR+) breast cancer (HR = 1.46; 1.15-1.85).

conclusionLong-term weight gain was positively associated with postmenopausal breast cancer in women who were lean at age 20, both in HRT ever users and non-users, and hormone-receptor-positive breast cancer.

Indexed as

Breast NeoplasmsAdultBody Mass IndexFemaleHumansMiddle AgedProspective StudiesRisk FactorsWeight GainYoung Adultbreast cancercohort studylong-term weight change

Identifiers

PMID34999853
PMCPMC8743116
OpenAlexW3136271322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.